1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow MaaT Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients MaaT013 - Acute Graft Versus Host Disease in Intestine, Steroid Refractory GVHD | Phase 3 | Active not recruiting | MaaT Pharma | 66 | 2022-03-25 | 2024-10-17 |
Austria (1) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Spain (1)